LNK Deficiency Decreases Obesity-Induced Insulin Resistance by Regulating GLUT4 Through the PI3K-Akt-AS160 Pathway in Adipose Tissue.

Xiaozhu Zhong,Chuanfeng Ke,Zhaoxi Cai,Hao Wu,Yang Ye,Xiaolin Liang,Liqun Yu,Sushi Jiang,Jun Shen,Laiyou Wang,Meiqing Xie,Guanlei Wang,Xiaomiao Zhao
DOI: https://doi.org/10.18632/aging.103658
2020-01-01
Aging
Abstract:In recent years, LNK, an adapter protein, has been found to be associated with metabolic diseases, including hypertension and diabetes. We found that the expression of LNK in human adipose tissue was positively correlated with serum glucose and insulin in obese people. We examined the role of LNK in insulin resistance and systemic energy metabolism using LNK-deficient mice (LNK-/-). With consumption of a high-fat diet, wild type (WT) mice accumulated more intrahepatic triglyceride, higher serum triglyceride (TG), free fatty acid (FFA) and high sensitivity C-reactive protein (hsCRP) compared with LNK-/- mice. However, there was no significant difference between LNK-/- and WT mice under normal chow diet. Meanwhile, glucose transporter 4 (GLUT4) expression in adipose tissue and insulin-stimulated glucose uptake in adipocytes were increased in LNK-/- mice. LNK-/- adipose tissue showed activated reactivity for IRS1/PI3K/Akt/AS160 signaling, and administration of a PI3K inhibitor impaired glucose uptake. In conclusion, LNK plays a pivotal role in adipose glucose transport by regulating insulin-mediated IRS1/PI3K/Akt/AS160 signaling.
What problem does this paper attempt to address?